Supporting this, snRNA-seq datasets confirmed that increased ACLY expression in malignant hepatocytes versus normal hepatocytes from patients with MASH-HCC (Fig. 5o and Extended Data Fig. 12d). Here, ACLY is linked to hepatocellular carcinoma.